Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary...
Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary...
biohaven在RESILIENt SMA研究中表示，Taldefgrobep alfa在运动功能测量-32量表的所有时间点上显示出临床意义的运动功能改善，但治疗组在主要指标上没有统计学上的分离...
Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary Outcome At Week 48 Compared To The Placebo+Standard Of Care Group
Biohaven表示，在弹性SMA研究中，Taldefgrobep Alfa在运动功能测量-32量表上显示，所有时间点的运动功能都有临床意义的改善，但与安慰剂+标准护理组相比，治疗部门在第48周的主要结局上并未在统计学上分开
资讯热榜
更新时间